561 results on '"Schnitzler, M"'
Search Results
102. Quantifying Prognostic Impact of Prescription Narcotics Use Before Kidney Transplantation through Linked Registry and Pharmaceutical Claims Data.
103. Differential Risks For 3-Year Adverse Outcomes After Kidney Transplant Based On Initial Immunosuppression and Incorporating Claims Data Records: A National Study.
104. Racial Variation in the Use of Antihypertensive Medications After Living Kidney Donation.
105. International Comparison of the Cost-Effectiveness of VADS as Bridge to Transplant.
106. Variation in the Incidence Biliary Complications in Liver Transplantation: Outcome and Economic Implications.
107. Incremental Cost-Effectiveness of Lung Transplant By Lung Allocation Score.
108. Costs of Pediatric Kidney Transplant.
109. The impact of direct‐acting antiviral agents on liver and kidney transplant costs and outcomes
110. A Double-Blind, Placebo Controlled, Randomized Trial to Assess the Impact of a Monthly Administration of 50,000 IU of Vitamin D3 for 6 Months on Serum Levels of 25-Hydroxyvitamin D in Healthy Young Adults
111. PRM18 Modeling Long-Term Health Outcomes in Chronic Kidney Disease
112. PUK4 Comparing Projected Outcomes of Renal Transplant Recipients Based on Trial Endpoint of Renal Function and Receiving Different Immunosuppressive Regimens in the United States
113. Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial
114. Transplantation / Clinical studies
115. Transplantation: clinical studies
116. APPLICATION OF A VALIDATED LONG-TERM RENAL TRANSPLANT GRAFT SURVIVAL PREDICTION MODEL TO EXPECTED BELATACEPT PHASE III TRIAL OUTCOMES
117. PREDICTION EQUATIONS FOR GRAFT FAILURE BASED ON 12-MONTH EGFR IN THE US KIDNEY TRANSPLANT POPULATION: A VALIDATION STUDY USING THE INTERNATIONAL PORT DATABASE
118. PROJECTING PATIENT OUTCOMES AT 20 YEARS BASED ON GRAFT FUNCTION FROM RANDOMIZED TRIALS OF IMMUNOSUPPRESSANTS AMONG RENAL TRANSPLANT RECIPIENTS IN THE UNITED STATES
119. THE RELATIONSHIP BETWEEN RENAL FUNCTION AND RENAL TRANSPLANT GRAFT FAILURE INCREASES OVER TIME
120. RELATIONSHIP BETWEEN 1-YEAR POST-TRANSPLANT ESTIMATED GLOMERULAR FILTRATION RATE AND LONG-TERM KIDNEY GRAFT SURVIVAL BY DONOR TYPE
121. 40-P: Patient factors associated with selection for kidney transplantation with positive CDC crossmatch
122. 277-P: Associations of HLA-mismatches with graft outcomes and costs of deceased-donor kidney transplantation
123. Long-term remission after CD34+-selected PBSCT in a patient with advanced intra-abdominal desmoplastic small round-cell tumor
124. Maintenance Steroid Therapy for Kidney Recipients—Not Ready for Relegation
125. 5 YEAR OUTCOMES IN A RANDOMIZED TRIAL COMPARING RABBIT ANTITHYMOCYTE GLOBULIN AND BASILIXIMAB IN KIDNEY TRANSPLANT RECIPIENTS: LINKING CLINICAL TRIAL DATA WITH REGISTRY DATA
126. THE INFLUENCE OF STATINS ON POLYOMA VIRUS
127. THYMOGLOBULIN INDUCTION IN LIVING DONOR RENAL TRANSPLANT RECIPIENTS: UPDATE OF THE TAILOR REGISTRY
128. Die essentielle Bedeutung des „Classical Transient Receptor Potential 6“ (TRPC6)-Ionenkanals für die hypoxische pulmonale Vasokonstriktion
129. Invest now to save later: The need for a national quality improvement initiative to reduce the costs of liver transplantation in children
130. Die essentielle Bedeutung des „Classical Transient Receptor Potential 6“ (TRPC6)-Ionenkanals für die hypoxische pulmonale Vasokonstriktion
131. Evidence of fractal structure for charge transport in carbon-nanotube/conjugated-polymer composites
132. Therapeutische und pflegerische Grundhaltungen in der qualifizierten Entgiftung opiatabhängiger Patientinnen und Patienten
133. DEVELOPMENT OF DIABETES MELLITUS AFTER RENAL TRANSPLANTATION AND TACROLIMUS DOSE ADJUSTMENT
134. HIGH DONOR ANTIBODY LEVEL AND HLA C7 PREDICT SUSTAINED BK-POLYOMA VIREMIA: RESULTS OF A RANDOMIZED PROSPECTIVE TRIAL
135. CYCLOSPORINE BASED, C2 MONITORED QUADRUPLE IMMUNOSUPPRESSIVE REGIMEN RESULTS IN CYCLOSPORINE MINIMIZATION AND COST REDUCTION IN RENAL TRANSPLANT RECIPIENTS
136. Renal graft survival with tacrolimus versus cyclosporine microemulsion - a registry analysis
137. MMF DOSE MODIFICATION FOLLOWING GASTROINTESTINAL COMPLICATIONS IN RENAL TRANSPLANTATION
138. INCIDENCE AND PREDICTORS OF MYOCARDIAL INFARCTION AFTER KIDNEY TRANSPLANTATION IN THE UNITED STATES
139. INTERNATIONAL ESTIMATES OF THE LIFE-YEARS AVAILABLE FROM POTENTIAL BUT UNPROCURED DECEASED ORGAN DONORS
140. Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation
141. Radiologische Befunddokumentation im Operationstunnel (Horizontalflow)
142. National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence‐Based Regimen Selection
143. The Impact of Redistricting Proposals on Health Care Expenditures for Liver Transplant Candidates and Recipients
144. DOSE REDUCTION OF RABBIT ATG IN ADULT RENAL TRANSPLANT RECIPIENTS-1 YEAR PILOT STUDY.
145. Angst als Begleitsymptom der Altersdepression
146. ECONOMIC COST OF EXPANDED CRITERIA DONORS IN CADAVERIC RENAL TRANSPLANTATION
147. ECONOMIC IMPLICATIONS OF CMV-SEROLOGY MATCHING IN KIDNEY TRANSPLANTATION
148. RELATIVE COST OF CADAVERIC VERSUS LIVING DONOR KIDNEY TRANSPLANTATION
149. AN OPEN-LABEL STUDY OF 3 DAYS OF THYMOGLOBULIN FOR INDUCTION IN ADULT RENAL TRANSPLANT RECIPIENTS
150. GANCICLOVIR HAS NO IMPACT ON HHV-7 LEUKODNAEMIA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.